Comprehensive follow-up care and life-threatening illnesses among high-risk infants: A randomized controlled trial

R S Broyles1, J E Tyson, E T Heyne

  • 1University of Texas-Houston Medical School, 6431 Fannin St, MSB 3. 228, Houston, TX 77030-1503, USA.

JAMA
|October 24, 2000
PubMed

Insights

Comprehensive care for high-risk infants significantly reduced life-threatening illnesses and intensive care admissions without increasing costs. This approach improves health outcomes for vulnerable urban newborns.

Area of Science:

  • Pediatrics
  • Health Services Research
  • Public Health

Background:

  • Inner-city high-risk infants often face fragmented healthcare, increasing their risk of serious illness.
  • Limited access to consistent medical care can exacerbate health issues in vulnerable newborns.

Purpose of the Study:

  • To determine if comprehensive follow-up care is a cost-effective strategy for reducing life-threatening illnesses in high-risk, inner-city infants.
  • To evaluate the impact of enhanced care access on severe health events and healthcare costs.

Main Methods:

  • A randomized controlled trial involving 887 very-low-birth-weight infants.
  • Infants were assigned to either routine follow-up care or comprehensive care with 24-hour caregiver access.
  • Life-threatening illnesses and hospital costs were assessed up to one year of age by blinded evaluators.

Main Results:

  • Comprehensive care led to significantly fewer life-threatening illnesses (48% reduction), intensive care admissions (57% reduction), and intensive care days (42% reduction).
  • Despite increased clinic visits and phone calls, comprehensive care did not increase overall estimated costs per infant.
  • Fewer infants in the comprehensive care group had unknown one-year outcomes compared to the routine care group.

Conclusions:

  • Comprehensive follow-up care provided by experienced caregivers is effective in reducing severe illness in high-risk inner-city infants.
  • This enhanced care model improves infant health outcomes without incurring additional healthcare expenses.
  • The study supports the implementation of comprehensive care programs for vulnerable urban infant populations.
Abstract

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.4K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413